Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Novel Oral Small Molecule GLP-1 Receptor Agonist (HRS-7535) in Healthy Subjects: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single- and Multiple-Ascending Dose (SAD and MAD) Study